Policy | Life Science Washington

LSW Briefs Lawmakers on Washington’s Life Sciences Ecosystem

Kaitlyn Campitiello — Wed, 02 Apr 2025 15:48:19 +0000

Last Friday, Life Science Washington’s Marc Cummings and Cyrus Biotechnology’s Lucas Nivon presented before the House Technology, Economic Development & Veterans Committee to highlight Washington’s thriving life sciences industry, and the urgent need to sustain its momentum.

We emphasized that our state’s success as a top 10 life science hub was built over decades through research, public investment, and entrepreneurial grit. However, with key programs like the Life Sciences Discovery Fund and R&D tax incentives having expired, Washington risks falling behind states doubling down on their support.

We delivered a clear message: with strategic reinvestment, we can expand jobs, attract capital, and drive life-saving advancements for years to come.

The post LSW Briefs Lawmakers on Washington’s Life Sciences Ecosystem appeared first on Life Science Washington.

Life Science Washington President & CEO Partners with Other Life Science Association Leaders to Oppose NIH Funding Cuts and Defend US Leadership in Biotechnology

Kaitlyn Campitiello — Tue, 25 Mar 2025 20:22:58 +0000

NIH funding is critical to maintaining American competitiveness and economic success. The Trump Administration’s proposed cuts to NIH’s indirect cost reimbursement threaten to undermine American exceptionalism, ceding our leadership in life sciences, global health, and biosecurity to China.

In a new op-ed for the Timmerman Report, Life Science Washington President and CEO Marc Cummings and other state biotech association leaders call on the Trump Administration to drop the case regarding NIH cuts and start a meaningful dialogue with industry and research leaders to maintain our position as the world’s dominant life science powerhouse.

The post Life Science Washington President & CEO Partners with Other Life Science Association Leaders to Oppose NIH Funding Cuts and Defend US Leadership in Biotechnology appeared first on Life Science Washington.

Washington State Lawmakers Seek to Further Curb Drug Prices as Biotech Leaders Raise Alarm

Kaitlyn Campitiello — Wed, 22 Feb 2023 17:54:24 +0000

Lawmakers in Washington state are considering legislation that would give a governor-appointed board extra authority to curtail the price of high-cost prescription medications.

Proponents say the legislation will increase access to medicines, but industry leaders and some patient groups say it will quash innovation and may curtail availability of some drugs for state residents.

The bill “really sends a question mark as to whether or not the state is committed to the industry and understands how it works,” said Marc Cummings, CEO of the trade group Life Science Washington, who signed a letter to lawmakers along with state biotech leaders urging lawmakers to reject the bill.

The new bill (HB 1269) goes beyond a drug pricing law passed last year in the state.

The post Washington State Lawmakers Seek to Further Curb Drug Prices as Biotech Leaders Raise Alarm appeared first on Life Science Washington.